Genetic loci associated with platelet traits and platelet disorders

Seminars in Thrombosis and Hemostasis

Volumn 39, Issue 3, 2013, Pages 291-305

  Bunimov, Natalia ^a   Fuller, Nola ^a   Hayward, Catherine M P ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

Author keywords

genome wide association studies; inherited platelet disorders; platelet aggregation; platelet function; platelet secretion

Indexed keywords

BAK1 PROTEIN; CADHERIN; CADHERIN 10; COLLAGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL 1; GUANOSINE DIPHOSPHATE MANNOSE; GUANOSINE DIPHOSPHATE MANNOSE 4,6 DEHYDRATASE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN B7; KV CHANNEL INTERACTING PROTEIN; KV CHANNEL INTERACTING PROTEIN 4; LYSOSOMAL ASSOCIATED TRANSMEMBRANE PROTEIN 4A; MAGI1 PROTEIN; MEMBRANE ASSOCIATED GUANYLATE CYCLASE KINASE; MEMBRANE METALLOENDOPEPTIDASE; MEMBRANE PROTEIN; NETRIN; PHOSPHATASE AND ACTIN REGULATOR; PROTEIN BCL 2; REGULATOR PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 3; RISTOCETIN; SYNDECAN 1; THROMBOPOIETIN; THROMBOXANE; UNC5C PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC TRAIT; HEREDITY; HISTOPATHOLOGY; HUMAN; INHERITANCE; MEGAKARYOCYTE; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RISK FACTOR; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE DISORDER; THROMBOCYTE FUNCTION;

BLOOD PLATELET DISORDERS; BLOOD PLATELETS; GENETIC LOCI; HUMANS; PLATELET AGGREGATION;

EID: 84875415140     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0033-1334466     Document Type: Article

References (136)

1. Gresele P., Page C. P., Fuster V., Vermylen J. Platelets in Thrombotic and Non-thrombotic Disorders. Cambridge, UK Cambridge University Press: 2002; 1 1124
2. Michelson A. D. Platelets. 3rd ed. Philadelphia, PA Elsevier/Academic Press: 2013; (in press)
3. Marder V. J., Aird W. C., Bennett J. S., Schulman S., White G. C. II. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 6th ed. Philadelphia, PA Lippincott Williams and Wilkins: 2012; 1 1592
4. Rowley J. W., Oler A. J., Tolley N. D., et al. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood: 2011; 118 14 e101 e111
5. Gnatenko D. V., Dunn J. J., Schwedes J., Bahou W. F. Transcript profiling of human platelets using microarray and serial analysis of gene expression (SAGE). Methods Mol Biol: 2009; 496 245 272
6. Senzel L., Gnatenko D. V., Bahou W. F. The platelet proteome. Curr Opin Hematol: 2009; 16 5 329 333
7. Bahou W. F. Platelet systems biology using integrated genetic and proteomic platforms. Thromb Res: 2012; 129 01 S38 S45
8. García A., Prabhakar S., Brock C. J., et al. Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry. Proteomics: 2004; 4 3 656 668 (Pubitemid 38339146)
9. García A., Prabhakar S., Hughan S., et al. Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins. Blood: 2004; 103 6 2088 2095 (Pubitemid 38326224)
10. García A., Zitzmann N., Watson S. P. Analyzing the platelet proteome. Semin Thromb Hemost: 2004; 30 4 485 489 (Pubitemid 39180723)
11. Watson S. P., Bahou W. F., Fitzgerald D., Ouwehand W., Rao A. K., Leavitt A. D. ISTH Platelet Physiology Subcommittee Mapping the platelet proteome: a report of the ISTH Platelet Physiology Subcommittee. J Thromb Haemost: 2005; 3 9 2098 2101 (Pubitemid 43086070)
12. Gaxiola B., Friedl W., Propping P. Epinephrine-induced platelet aggregation. A twin study. Clin Genet: 1984; 26 6 543 548 (Pubitemid 15209293)
13. Kunicki T. J., Williams S. A., Nugent D. J. Genetic variants that affect platelet function. Curr Opin Hematol: 2012; 19 5 371 379
14. Ferreira M. A., Hottenga J. J., Warrington N. M., et al. Sequence variants in three loci influence monocyte counts and erythrocyte volume. Am J Hum Genet: 2009; 85 5 745 749
15. Meisinger C., Prokisch H., Gieger C., et al. A genome-wide association study identifies three loci associated with mean platelet volume. Am J Hum Genet: 2009; 84 1 66 71
16. Guerrero J. A., Rivera J., Quiroga T., et al. Novel loci involved in platelet function and platelet count identified by a genome-wide study performed in children. Haematologica: 2011; 96 9 1335 1343
17. Mathias R. A., Kim Y., Sung H., et al. A combined genome-wide linkage and association approach to find susceptibility loci for platelet function phenotypes in European American and African American families with coronary artery disease. BMC Med Genomics: 2010; 3 22
18. Kamatani Y., Matsuda K., Okada Y., et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet: 2010; 42 3 210 215
19. Soranzo N., Rendon A., Gieger C., et al. A novel variant on chromosome 7q22.3 associated with mean platelet volume, counts, and function. Blood: 2009; 113 16 3831 3837
20. Yang Q., Kathiresan S., Lin J. P., Tofler G. H., O'Donnell C. J. Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study. BMC Med Genet: 2007; 8 01 S12
21. Lo K. S., Wilson J. G., Lange L. A., et al. Genetic association analysis highlights new loci that modulate hematological trait variation in Caucasians and African Americans. Hum Genet: 2011; 129 3 307 317
22. Gieger C., Radhakrishnan A., Cvejic A., et al. New gene functions in megakaryopoiesis and platelet formation. Nature: 2011; 480 7376 201 208
23. Soranzo N., Spector T. D., Mangino M., et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet: 2009; 41 11 1182 1190
24. Qayyum R., Snively B. M., Ziv E., et al. A meta-analysis and genome-wide association study of platelet count and mean platelet volume in African Americans. PLoS Genet: 2012; 8 3 e1002491
25. Johnson A. D., Yanek L. R., Chen M. H., et al. Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet: 2010; 42 7 608 613
26. Goodall A. H., Burns P., Salles I., et al. Bloodomics Consortium Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function. Blood: 2010; 116 22 4646 4656
27. Snoep J. D., Gaussem P., Eikenboom J. C., et al. The minor allele of GP6 T13254C is associated with decreased platelet activation and a reduced risk of recurrent cardiovascular events and mortality: results from the SMILE-Platelets project. J Thromb Haemost: 2010; 8 11 2377 2384
28. Edelstein L. C., Luna E. J., Gibson I. B., et al. Human genome-wide association and mouse knockout approaches identify platelet supervillin as an inhibitor of thrombus formation under shear stress. Circulation: 2012; 125 22 2762 2771
29. Nagalla S., Shaw C., Kong X., et al. Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood: 2011; 117 19 5189 5197
30. Bray P. F., Mathias R. A., Faraday N., et al. Heritability of platelet function in families with premature coronary artery disease. J Thromb Haemost: 2007; 5 8 1617 1623 (Pubitemid 47091401)
31. Herrera-Galeano J. E., Becker D. M., Wilson A. F., et al. A novel variant in the platelet endothelial aggregation receptor-1 gene is associated with increased platelet aggregability. Arterioscler Thromb Vasc Biol: 2008; 28 8 1484 1490
32. Faraday N., Yanek L. R., Yang X. P., et al. Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression. Blood: 2011; 118 12 3367 3375
33. Hayward C. P., Pai M., Liu Y., et al. Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. J Thromb Haemost: 2009; 7 4 676 684
34. Pai M., Wang G., Moffat K. A., et al. Diagnostic usefulness of a lumi-aggregometer adenosine triphosphate release assay for the assessment of platelet function disorders. Am J Clin Pathol: 2011; 136 3 350 358
35. Lo K. A., Bauchmann M. K., Baumann A. P., et al. Genome-wide profiling of H3K56 acetylation and transcription factor binding sites in human adipocytes. PLoS ONE: 2011; 6 6 e19778
36. Kunicki T. J., Nugent D. J. The genetics of normal platelet reactivity. Blood: 2010; 116 15 2627 2634
37. Ballmaier M., Germeshausen M. Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment. Semin Thromb Hemost: 2011; 37 6 673 681
38. Hirsch E., Bosco O., Tropel P., et al. Resistance to thromboembolism in PI3Kgamma-deficient mice. FASEB J: 2001; 15 11 2019 2021
39. Pozgajová M., Sachs U. J., Hein L., Nieswandt B. Reduced thrombus stability in mice lacking the alpha2A-adrenergic receptor. Blood: 2006; 108 2 510 514 (Pubitemid 44061349)
40. Kauskot A., Di Michele M., Loyen S., Freson K., Verhamme P., Hoylaerts M. F. A novel mechanism of sustained platelet αIIbβ3 activation via PEAR1. Blood: 2012; 119 17 4056 4065
41. Wang W., Gilligan D. M., Sun S., Wu X., Reems J. A. Distinct functional effects for dynamin 3 during megakaryocytopoiesis. Stem Cells Dev: 2011; 20 12 2139 2151
42. Jedlitschky G., Cattaneo M., Lubenow L. E., et al. Role of MRP4 (ABCC4) in platelet adenine nucleotide-storage: evidence from patients with delta-storage pool deficiencies. Am J Pathol: 2010; 176 3 1097 1103
43. Côté G. P. Structural and functional properties of the non-muscle tropomyosins. Mol Cell Biochem: 1983; 57 2 127 146 (Pubitemid 14205116)
44. Lang N. N., Gumundsdóttir I. J., Newby D. E. Vascular PAR-1: activity and antagonism. Cardiovasc Ther: 2011; 29 6 349 361
45. García P., Berlanga O., Vegiopoulos A., Vyas P., Frampton J. c-Myb and GATA-1 alternate dominant roles during megakaryocyte differentiation. J Thromb Haemost: 2011; 9 8 1572 1581
46. Schmitz G., Schambeck C. M. Molecular defects in the ABCA1 pathway affect platelet function. Pathophysiol Haemost Thromb: 2006; 35 1-2 166 174
47. Fock E. L., Yan F., Pan S., Chong B. H. NF-E2-mediated enhancement of megakaryocytic differentiation and platelet production in vitro and in vivo. Exp Hematol: 2008; 36 1 78 92 (Pubitemid 350266967)
48. Castermans D., Volders K., Crepel A., et al. SCAMP5, NBEA and AMISYN: three candidate genes for autism involved in secretion of large dense-core vesicles. Hum Mol Genet: 2010; 19 7 1368 1378
49. Israels S. J., McMillan-Ward E. M. Platelet tetraspanin complexes and their association with lipid rafts. Thromb Haemost: 2007; 98 5 1081 1087 (Pubitemid 350091138)
50. Mangin P. H., Kleitz L., Boucheix C., Gachet C., Lanza F. CD9 negatively regulates integrin alphaIIbbeta3 activation and could thus prevent excessive platelet recruitment at sites of vascular injury. J Thromb Haemost: 2009; 7 5 900 902
51. Kojima H., Kanada H., Shimizu S., et al. CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells. J Biol Chem: 2003; 278 38 36748 36753 (Pubitemid 37140008)
52. Gekas C., Rhodes K. E., Gereige L. M., et al. Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis. Blood: 2009; 113 15 3461 3471
53. Antl M., von Brühl M. L., Eiglsperger C., et al. IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. Blood: 2007; 109 2 552 559 (Pubitemid 46105953)
54. Buitrago L., Tsygankov A., Sanjay A., Kunapuli S. P. Cbl proteins in platelet activation. Platelets: 2012; August 29
55. Derbent M., Öncel Y., Tokel K., et al. Clinical and hematologic findings in Noonan syndrome patients with PTPN11 gene mutations. Am J Med Genet A: 2010; 152A 11 2768 2774
56. Catani L., Sollazzo D., Ricci F., et al. The CD47 pathway is deregulated in human immune thrombocytopenia. Exp Hematol: 2011; 39 4 486 494
57. Josefsson E. C., James C., Henley K. J., et al. Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets. J Exp Med: 2011; 208 10 2017 2031
58. Hayward C. P., Favaloro E. J. Diagnostic evaluation of platelet disorders: the past, the present, and the future. Semin Thromb Hemost: 2009; 35 2 127 130
59. Nurden A., Nurden P. Advances in our understanding of the molecular basis of disorders of platelet function. J Thromb Haemost: 2011; 9 01 76 91
60. Nurden A. T., Freson K., Seligsohn U. Inherited platelet disorders. Haemophilia: 2012; 18 04 154 160
61. Dumont B., Lasne D., Rothschild C., et al. Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations. Blood: 2009; 114 9 1900 1903
62. Hermans C., Wittevrongel C., Thys C., Smethurst P. A., Van Geet C., Freson K. A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder. J Thromb Haemost: 2009; 7 8 1356 1363
63. Nurden A. T., Pillois X., Fiore M., Heilig R., Nurden P. Glanzmann thrombasthenia-like syndromes associated with Macrothrombocytopenias and mutations in the genes encoding the αIIbβ3 integrin. Semin Thromb Hemost: 2011; 37 6 698 706
64. Navarro-Núñez L., Teruel R., Antón A. I., et al. Rare homozygous status of P43 β1-tubulin polymorphism causes alterations in platelet ultrastructure. Thromb Haemost: 2011; 105 5 855 863
65. Kunishima S., Kobayashi R., Itoh T. J., Hamaguchi M., Saito H. Mutation of the beta1-tubulin gene associated with congenital macrothrombocytopenia affecting microtubule assembly. Blood: 2009; 113 2 458 461
66. Hirano K., Kuwasako T., Nakagawa-Toyama Y., Janabi M., Yamashita S., Matsuzawa Y. Pathophysiology of human genetic CD36 deficiency. Trends Cardiovasc Med: 2003; 13 4 136 141 (Pubitemid 36547681)
67. Castilloux J. F., Moffat K. A., Liu Y., Seecharan J., Pai M., Hayward C. P. A prospective cohort study of light transmission platelet aggregometry for bleeding disorders: is testing native platelet-rich plasma non-inferior to testing platelet count adjusted samples? Thromb Haemost: 2011; 106 4 675 682
68. Hayward C. P., Moffat K. A., Castilloux J. F., et al. Simultaneous measurement of adenosine triphosphate release and aggregation potentiates human platelet aggregation responses for some subjects, including persons with Quebec platelet disorder. Thromb Haemost: 2012; 107 4 726 734
69. Gnatenko D. V., Perrotta P. L., Bahou W. F. Proteomic approaches to dissect platelet function: Half the story. Blood: 2006; 108 13 3983 3991 (Pubitemid 44913266)
70. Gnatenko D. V., Zhu W., Bahou W. F. Multiplexed genetic profiling of human blood platelets using fluorescent microspheres. Thromb Haemost: 2008; 100 5 929 936
71. O'Neill E. E., Brock C. J., von Kriegsheim A. F., et al. Towards complete analysis of the platelet proteome. Proteomics: 2002; 2 3 288 305 (Pubitemid 34269983)
72. Perrotta P. L., Bahou W. F. Proteomics in platelet science. Curr Hematol Rep: 2004; 3 6 462 469
73. Maynard D. M., Heijnen H. F., Horne M. K., White J. G., Gahl W. A. Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost: 2007; 5 9 1945 1955 (Pubitemid 47288954)
74. Parguiña A. F., Rosa I., García A. Proteomics applied to the study of platelet-related diseases: aiding the discovery of novel platelet biomarkers and drug targets. J Proteomics: 2012; 76 Spec No 275 286
75. Balduini C. L., Pecci A., Norris P. Diagnosis and management of inherited thrombocytopenias. Semin Thromb Hemost: 2013;; doi:http://dx.doi.org/ 10.1055/s-0032-1333540
76. Hayward C. P., Bunimov N. Thrombocytopenic platelet disorders. Semin Thromb Hemost: 2011; 37 6 617 620
77. Althaus K., Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost: 2009; 35 2 189 203
78. Balduini C. L., Pecci A., Savoia A. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. Br J Haematol: 2011; 154 2 161 174
79. Nurden A. T., Fiore M., Nurden P., Pillois X. Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models. Blood: 2011; 118 23 5996 6005
80. Noris P., Guidetti G. F., Conti V., et al. Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia. Thromb Haemost: 2006; 95 3 483 489
81. 12 receptor for adenosine diphosphate: congenital and drug-induced defects. Blood: 2011; 117 7 2102 2112
82. Oury C., Toth-Zsamboki E., Van Geet C., et al. A natural dominant negative P2X1 receptor due to deletion of a single amino acid residue. J Biol Chem: 2000; 275 30 22611 22614 (Pubitemid 30646139)
83. Kamae T., Kiyomizu K., Nakazawa T., et al. Bleeding tendency and impaired platelet function in a patient carrying a heterozygous mutation in the thromboxane A2 receptor. J Thromb Haemost: 2011; 9 5 1040 1048
84. Mumford A. D., Dawood B. B., Daly M. E., et al. A novel thromboxane A2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis. Blood: 2010; 115 2 363 369
85. Fuse I., Higuchi W., Aizawa Y. Pathogenesis of a bleeding disorder characterized by platelet unresponsiveness to thromboxane A2. Semin Thromb Hemost: 2000; 26 1 43 45
86. Higuchi W., Fuse I., Hattori A., Aizawa Y. Mutations of the platelet thromboxane A2 (TXA2) receptor in patients characterized by the absence of TXA2-induced platelet aggregation despite normal TXA2 binding activity. Thromb Haemost: 1999; 82 5 1528 1531 (Pubitemid 29527650)
87. Hirata T., Kakizuka A., Ushikubi F., Fuse I., Okuma M., Narumiya S. Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. J Clin Invest: 1994; 94 4 1662 1667
88. Nurden P., Debili N., Coupry I., et al. Thrombocytopenia resulting from mutations in filamin A can be expressed as an isolated syndrome. Blood: 2011; 118 22 5928 5937
89. Cramer Bordé E., Ouzegdouh Y., Ledgerwood E. C., Morison I. M. Congenital thrombocytopenia and cytochrome C mutation: a matter of birth and death. Semin Thromb Hemost: 2011; 37 6 664 672
90. Geneviève D., Proulle V., Isidor B., et al. Thromboxane synthase mutations in an increased bone density disorder (Ghosal syndrome). Nat Genet: 2008; 40 3 284 286 (Pubitemid 351311762)
91. Michaud J., Wu F., Osato M., et al. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. Blood: 2002; 99 4 1364 1372 (Pubitemid 34547093)
92. Millikan P. D., Balamohan S. M., Raskind W. H., Kacena M. A. Inherited thrombocytopenia due to GATA-1 mutations. Semin Thromb Hemost: 2011; 37 6 682 689
93. Thompson A. A., Nguyen L. T. Amegakaryocytic thrombocytopenia and radio-ulnar synostosis are associated with HOXA11 mutation. Nat Genet: 2000; 26 4 397 398
94. Kahr W. H., Hinckley J., Li L., et al. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat Genet: 2011; 43 8 738 740
95. Gunay-Aygun M., Falik-Zaccai T. C., Vilboux T., et al. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules. Nat Genet: 2011; 43 8 732 734
96. Albers C. A., Cvejic A., Favier R., et al. Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome. Nat Genet: 2011; 43 8 735 737
97. Abu-Sa'da O., Barbar M., Al-Harbi N., Taha D. Arthrogryposis, renal tubular acidosis and cholestasis (ARC) syndrome: two new cases and review. Clin Dysmorphol: 2005; 14 4 191 196 (Pubitemid 41400275)
98. Meng R., Wang Y., Yao Y., et al. SLC35D3 delivery from megakaryocyte early endosomes is required for platelet dense granule biogenesis and is differentially defective in Hermansky-Pudlak syndrome models. Blood: 2012; 120 2 404 414
99. Masliah-Planchon J., Darnige L., Bellucci S. Molecular determinants of platelet delta storage pool deficiencies: an update. Br J Haematol: 2013; 160 1 5 11
100. Wei M. L. Hermansky-Pudlak syndrome: a disease of protein trafficking and organelle function. Pigment Cell Res: 2006; 19 1 19 42
101. Badolato R., Prandini A., Caracciolo S., et al. Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome. Blood: 2012; 119 13 3185 3187
102. Blavignac J., Bunimov N., Rivard G. E., Hayward C. P. Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment. Semin Thromb Hemost: 2011; 37 6 713 720
103. Hayward C. P., Rivard G. E. Quebec platelet disorder. Expert Rev Hematol: 2011; 4 2 137 141
104. Paterson A. D., Rommens J. M., Bharaj B., et al. Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene. Blood: 2010; 115 6 1264 1266
105. Van Geet C., Izzi B., Labarque V., Freson K. Human platelet pathology related to defects in the G-protein signaling cascade. J Thromb Haemost: 2009; 7 01 282 286
106. Gabbeta J., Vaidyula V. R., Dhanasekaran D. N., Rao A. K. Human platelet Galphaq deficiency is associated with decreased Galphaq gene expression in platelets but not neutrophils. Thromb Haemost: 2002; 87 1 129 133 (Pubitemid 34092587)
107. Freson K., Thys C., Wittevrongel C., et al. Pseudohypoparathyroidism type Ib with disturbed imprinting in the GNAS1 cluster and Gsalpha deficiency in platelets. Hum Mol Genet: 2002; 11 22 2741 2750 (Pubitemid 35214901)
108. Noé L., Di Michele M., Giets E., et al. Platelet Gs hypofunction and abnormal morphology resulting from a heterozygous RGS2 mutation. J Thromb Haemost: 2010; 8 7 1594 1603
109. Jurk K., Schulz A. S., Kehrel B. E., et al. Novel integrin-dependent platelet malfunction in siblings with leukocyte adhesion deficiency-III (LAD-III) caused by a point mutation in FERMT3. Thromb Haemost: 2010; 103 5 1053 1064
110. Hayward C. P. Diagnostic evaluation of platelet function disorders. Blood Rev: 2011; 25 4 169 173
111. Kuijpers T. W., van de Vijver E., Weterman M. A., et al. LAD-1/variant syndrome is caused by mutations in FERMT3. Blood: 2009; 113 19 4740 4746
112. Defreyn G., Machin S. J., Carreras L. O., Dauden M. V., Chamone D. A., Vermylen J. Familial bleeding tendency with partial platelet thromboxane synthetase deficiency: reorientation of cyclic endoperoxide metabolism. Br J Haematol: 1981; 49 1 29 41 (Pubitemid 11051320)
113. Di Paola J., Johnson J. Thrombocytopenias due to gray platelet syndrome or THC2 mutations. Semin Thromb Hemost: 2011; 37 6 690 697
114. Lhermusier T., Chap H., Payrastre B. Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome. J Thromb Haemost: 2011; 9 10 1883 1891
115. Weiss H. J. Impaired platelet procoagulant mechanisms in patients with bleeding disorders. Semin Thromb Hemost: 2009; 35 2 233 241
116. Albers C. A., Paul D. S., Schulze H., et al. Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome. Nat Genet: 2012; 44 4 435 439, S1-S2
117. Huizing M., Parkes J. M., Helip-Wooley A., White J. G., Gahl W. A. Platelet alpha granules in BLOC-2 and BLOC-3 subtypes of Hermansky-Pudlak syndrome. Platelets: 2007; 18 2 150 157 (Pubitemid 46398993)
118. Thrasher A. J. New insights into the biology of Wiskott-Aldrich syndrome (WAS). Hematology (Am Soc Hematol Educ Program): 2009; 1 132 138
119. Othman M. Platelet-type Von Willebrand disease: three decades in the life of a rare bleeding disorder. Blood Rev: 2011; 25 4 147 153
120. Owen C. Insights into familial platelet disorder with propensity to myeloid malignancy (FPD/AML). Leuk Res: 2010; 34 2 141 142
121. Raslova H., Komura E., Le Couédic J. P., et al. FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia. J Clin Invest: 2004; 114 1 77 84 (Pubitemid 39071646)
122. Favier R., Jondeau K., Boutard P., et al. Paris-Trousseau syndrome: clinical, hematological, molecular data of ten new cases. Thromb Haemost: 2003; 90 5 893 897 (Pubitemid 37427859)
123. Noris P., Perrotta S., Seri M., et al. Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families. Blood: 2011; 117 24 6673 6680
124. Mezzano D., Quiroga T., Pereira J. The level of laboratory testing required for diagnosis or exclusion of a platelet function disorder using platelet aggregation and secretion assays. Semin Thromb Hemost: 2009; 35 2 242 254
125. Quiroga T., Goycoolea M., Matus V., et al. Diagnosis of mild platelet function disorders. Reliability and usefulness of light transmission platelet aggregation and serotonin secretion assays. Br J Haematol: 2009; 147 5 729 736
126. Hayward C. P., Moffat K. A., Liu Y. Laboratory investigations for bleeding disorders. Semin Thromb Hemost: 2012; 38 7 742 752
127. Gunay-Aygun M., Huizing M., Gahl W. A. Molecular defects that affect platelet dense granules. Semin Thromb Hemost: 2004; 30 5 537 547 (Pubitemid 39426386)
128. Sandrock K., Zieger B. Current Strategies in Diagnosis of Inherited Storage Pool Defects. Transfus Med Hemother: 2010; 37 5 248 258
129. Corral J., González-Conejero R., Pujol-Moix N., Domenech P., Vicente V. Mutation analysis of HPS1, the gene mutated in Hermansky-Pudlak syndrome, in patients with isolated platelet dense-granule deficiency. Haematologica: 2004; 89 3 325 329 (Pubitemid 38788418)
130. Cattaneo M., Lecchi A., Lombardi R., Gachet C., Zighetti M. L. Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2CYC receptors. Arterioscler Thromb Vasc Biol: 2000; 20 11 E101 E106
131. Jagadeeswaran P. Zebrafish: a tool to study hemostasis and thrombosis. Curr Opin Hematol: 2005; 12 2 149 152 (Pubitemid 40315700)
132. Dubé J. N., Drouin J., Aminian M., Plant M. H., Laneuville O. Characterization of a partial prostaglandin endoperoxide H synthase-1 deficiency in a patient with a bleeding disorder. Br J Haematol: 2001; 113 4 878 885 (Pubitemid 32634753)
133. Isidor B., Dagoneau N., Huber C., et al. A gene responsible for Ghosal hemato-diaphyseal dysplasia maps to chromosome 7q33-34. Hum Genet: 2007; 121 2 269 273 (Pubitemid 46404460)
134. Pham A., Wang J. Bernard-Soulier syndrome: an inherited platelet disorder. Arch Pathol Lab Med: 2007; 131 12 1834 1836 (Pubitemid 350294586)
135. Toriello H. V. Thrombocytopenia-absent radius syndrome. Semin Thromb Hemost: 2011; 37 6 707 712
136. Huizing M., Helip-Wooley A., Westbroek W., Gunay-Aygun M., Gahl W. A. Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics. Annu Rev Genomics Hum Genet: 2008; 9 359 386